![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.395 | -8.31% | 4.36 | 4.35 | 4.69 | 4.75 | 4.36 | 4.75 | 198,046 | 12:39:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.50 | 9.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/8/2020 06:38 | Check out the news at mgc in oz, phase 2 trials passed on covid treatment | ![]() kirk2 | |
20/8/2020 06:09 | Beta interferon, an anti-inflammatory drug that has already been approved for treatment of multiple sclerosis, is being paired with remdesivir in the latest phase of a federal coronavirus trial, The New York Times reports. The results of the study's second phase are still being evaluated — and scientists are hopeful. Beta interferon is already on the market, and has shown promise against the new coronavirus, killing it (along with the SARS and MERS coronaviruses) in lab studies. Additionally, tests in the United Kingdom and Hong Kong showed the drug performed better among COVID-19 patients than the placebo it was up against. Both those studies were too small to come away with anything definitive, but the U.S. trial should be large enough to get a better sense of its ability. [The New York Times] | ![]() dafad | |
20/8/2020 05:58 | If that is the case then you would think it would be Finn Cap as they are the house broker.Just my opinion | nortic 007 | |
20/8/2020 05:55 | It's most likely to be one big trade for a number of different accounts. It's then booked as a lump and then readjusted in checking...... but whatever it is there's a taker at the other side which is good. | nortic 007 | |
20/8/2020 03:46 | Sloppy, my target on positive news would be £12- £25 fair value 🚀 | ![]() strongbuy | |
19/8/2020 23:23 | Not certain, but I suspect we will find out why very soon. | the real capitalcity | |
19/8/2020 23:12 | Anyone suggest why so many 10k(NMS) trades are late reported? | ![]() wetdream | |
19/8/2020 21:43 | Stop what? Perfectly reasonable question, surely? | ![]() sloppyjoe2 | |
19/8/2020 21:36 | Strongbuy - so what's *your* price target short, medium and long-term? | ![]() sloppyjoe2 | |
19/8/2020 21:14 | Sloppy, they are rockets, this one is going where they go....into orbit 😉🚀 | ![]() strongbuy | |
19/8/2020 20:31 | Strongbuy - I'm on my mobile but I assume those are rockets at the end of your post ;-) Fingers crossed you're right. Bring it on! | ![]() sloppyjoe2 | |
19/8/2020 20:30 | strongbuy, Good spot re Phlexglobal. | ![]() sikhthetech |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions